An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancer

Posted by & filed under Uncategorized.

“Women undergoing treatment for breast cancer require frequent clinic visits for maintenance of therapy. With COVID-19 causing health care disruptions, it is important to learn about how this population’s access to health care has changed.” The study linked below was co-authored by two of our very own – Dr. Gregory Vidal and Andrea Curry, and compares self-reported… Read more »

Reversing resistance to PD-1 inhibitors with combination immunotherapy in patients with advanced melanoma

Posted by & filed under Uncategorized.

West Cancer Center & Research Institute’s Ari Vanderwalde, MD, MPH is a SWOG (a National Cancer Institute supported organization that conducts clinical trials in adults) investigator and study chair for a trial that addresses advanced melanoma patients who are resistant to PD-1 inhibitors. Over 40% of these patients don’t respond to PD-1 inhibitors, widely used… Read more »